GAO Ruzhen, FAN Yue, YANG Tengyu, LI Dongdong, GUO Ying, JIANG Hong, XU Yingchun, CHEN Xiaowei. Results of Neonatal Genetic Screening for Hearing Loss in Peking Union Medical College Hospital in the Past 10 Years[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1020-1027. DOI: 10.12290/xhyxzz.2022-0281
Citation: GAO Ruzhen, FAN Yue, YANG Tengyu, LI Dongdong, GUO Ying, JIANG Hong, XU Yingchun, CHEN Xiaowei. Results of Neonatal Genetic Screening for Hearing Loss in Peking Union Medical College Hospital in the Past 10 Years[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1020-1027. DOI: 10.12290/xhyxzz.2022-0281

Results of Neonatal Genetic Screening for Hearing Loss in Peking Union Medical College Hospital in the Past 10 Years

Funds: 

CAMS Innovations Fund for Medical Sciences CIFMS 2021-I2M-1-003

National Natural Science Foundation of China 81974143

More Information
  • Corresponding author:

    CHEN Xiaowei, E-mail: chenxw_pumch@163.com

  • Received Date: May 17, 2022
  • Accepted Date: July 31, 2022
  • Issue Publish Date: November 29, 2022
  •   Objective  To explore the operation status and effect of the neonatal deafness gene screeningin Beijing Union Medical College Hospital for the past 10 years and analyze the follow-up, genetic consultation and intervention to improve the quality of neonatal deafness gene screening.
      Methods  From April 2012 to March 2022, the screening data of newborns with deafness genetic screening by microarray microarray in Peking Union Medical College Hospital, and the data from the genetic counseling clinic of Peking Union Medical College Hospital were retrospectively collected. The mutation loci, mutation types, genetic clinic visits and follow-up interventions of newborns who did not pass the deafness genetic screening were analyzed.
      Results  Among 165 813 newborns, 8019 samples "failed" in the screening, accounting for 4.84%. Of the "failed" samples, 4173 cases carried GJB2 gene mutation, with a carrying rate of 2.52%; 3016 cases carried SLC26A4 gene mutation, with a carrying rate of 1.82%;570 cases carried GJB3 gene mutation, with a carrying rate of 0.34%; 405 cases carried homogeneous or heterogeneous mutation in 12S rRNA, with a carrying rate of 0.24%. During the screening, multiple mutation carriers were identified in 126 cases, all of whom had normal hearing at follow-up and were not given special intervention; 44 cases of deafness causing genotypes (except those at risk of drug-induced hearing loss), all of whom were given different interventions according to the degree of hearing loss; the presence of drug-sensitive deafness genotype was found in 405 cases, all of which were warned by drug warning cards for newborns and their maternal family members about drug use. The overall lost follow-up rate was 0.12%(204/165 813), and the overall genetic counselling rate of newborns who failed the screening was 46.10%(3697/8019). Among them, the lost rate of the first stage (from April 2012 to March 2013), the second stage (from April 2013 to December 2017) and the third stage (from January 2018 to March 2022) were 0.63%(72/11 489), 0.10%(80/81 663) and 0.07%(52/72 661), respectively. The visiting rate of genetic clinic was 38.05%(207/544), 39.44% (1496/3793) and 54.16%(1994/3682), respectively. The Cochran-Armitage trend test showed that the lost rate progressively lowered and the visiting rate gradually increased in the 3 stages (all P < 0.001).
      Conclusion  In the past 10 years, a thorough screening, follow-up, consultation and intervention platform has been established, which can help us in the early warning, early diagnosis and early intervention of families and individuals at risk of hearing impairment.
  • [1]
    高儒真, 陈晓巍, 历东东, 等. 新生儿耳聋易感基因筛查及咨询的临床意义[J]. 中国听力语言康复科学杂志, 2015, 13: 166-171.
    [2]
    王秋菊. 新生儿听力及基因联合筛查: 中国模式与未来发展[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28: 1733-1736. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201422002.htm
    [3]
    Chan DK, Chang KW. GJB2-associated hearing loss: systematic review of worldwide prevalence, genotype, and auditory phenotype[J]. Laryngoscope, 2014, 124: E34-E53. DOI: 10.1002/lary.24332
    [4]
    Kim BG, Shin JW, Park HJ, et al. Limitations of hearing screening in newborns with PDS mutations[J]. Int J Pediatr Otorhinolaryngol, 2013, 77: 833-837. DOI: 10.1016/j.ijporl.2013.02.023
    [5]
    Dai P, Huang LH, Wang GJ, et al. Concurrent Hearing and Genetic Screening of 180, 469 Neonates with Follow-up in Beijing, China[J]. Am J Hum Genet, 2019, 105: 803-812. DOI: 10.1016/j.ajhg.2019.09.003
    [6]
    Norris VW, Arnos KS, Hanks WD, et al. Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness[J]. Ear Hear, 2006, 27: 732-741. DOI: 10.1097/01.aud.0000240492.78561.d3
    [7]
    Minami SB, Mutai H, Nakano A, et al. GJB2-associated hearing loss undetected by hearing screening of newborns[J]. Gene, 2013, 532: 41-45. DOI: 10.1016/j.gene.2013.08.094
    [8]
    Pagarkar W, Bitner-Glindzicz M, Knight J, et al. Late postnatal onset of hearing loss due to GJB2 mutations[J]. Int J Pediatr Otorhinolaryngol, 2006, 70: 1119-1124. DOI: 10.1016/j.ijporl.2005.10.026
    [9]
    Xia JH, Liu CY, Tang BS, et al. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment[J]. Nat Genet, 1998, 20: 370-373. DOI: 10.1038/3845
    [10]
    刘新, 戴朴, 黄德亮, 等. 线粒体DNA A1555G突变大规模筛查及其预防意义探讨[J]. 中华医学杂志, 2006, 86: 1318-1322. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYX200619006.htm
    [11]
    戴朴. 重视中国聋人群体中遗传性耳聋筛查和预防工作[J]. 中国听力语言康复科学杂志, 2008, 6: 10-11. https://www.cnki.com.cn/Article/CJFDTOTAL-TLKF200803002.htm
    [12]
    吴皓, 黄治物, 杨涛. 先天性耳聋三级防控体系建设[J]. 听力学及言语疾病杂志, 2017, 25: 1-4. https://www.cnki.com.cn/Article/CJFDTOTAL-TLXJ201701001.htm
    [13]
    王秋菊, 陈晓巍. 关注聋病遗传咨询中的罕见病[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33: 799-803. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201909002.htm
    [14]
    Squerda M, Palau F, Lorenzo D, et al. Ethical questions concerning newborn genetic screening[J]. Clin Genet, 2021, 99: 93-98.
  • Related Articles

    [1]BAI Xue, LI Naishi. Review the In-Hospital Visits and Follow-up Work in the Early Stage of PUMCH from the Medical Record of the Social Service Department of China's First Insulinoma Case[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1230-1232. DOI: 10.12290/xhyxzz.2023-0654
    [2]GU Xiaoyang. Introduction and Production Plan of Insulin by Internal Medicine Department of Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 229-232. DOI: 10.12290/xhyxzz.2023-0183
    [3]GUO Xiaopeng, ZHANG Xiao, XING Hao, WANG Shishuai, YAO Yong, WEI junji, MA Wenbin, WANG Yu, GAO Jun. Exploration and Application of Microsurgical Training in Young Neurosurgeons at Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1106-1110. DOI: 10.12290/xhyxzz.2022-0529
    [4]GU Xiaoyang, MA Mingsheng, SONG Hongmei. Locating Biomedicine in China: the Development of the Division of Pediatrics in Peking Union Medical College Hospital(1922—1942)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 517-524. DOI: 10.12290/xhyxzz.2021-0664
    [5]JING Quan, LIU Jihai. Honor, Responsibility and Mission: A Silhouette of Clinical Teaching in Peking Union Medical College Hospital in 1925[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 158-164. DOI: 10.12290/xhyxzz.20200016
    [6]ZHU Zhu, ZHANG Bo, LI Naishi, TANG Yan, MEI Dan, LI Dakui. Academic Influence of the Pharmacy Department of Peking Union Medical College Hospital from 1921 to 1951[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 813-818. DOI: 10.12290/xhyxzz.20200232
    [7]Zhu ZHU, Bo ZHANG, Nai-shi LI, Yan TANG, Dan MEI, Da-kui LI. Outline on the Formulary of Peking Union Medical College Hospital Pressed in 1927[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 631-637. DOI: 10.3969/j.issn.1674-9081.2020.05.022
    [8]Xi-ya WANG, Cheng ZHEN. Development of Neurology and Psychiatry in Peking Union Medical College Hospital and Contributions of the Foreign Heads of the Division(1921—1941)[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 492-499. DOI: 10.3969/j.issn.1674-9081.2020.04.023
    [9]Xiao-yang GU. A Sketch of Medicine and Society in the Era of Republican China: Social Service Department of Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 304-309. DOI: 10.3969/j.issn.1674-9081.2019.03.021
    [10]Zhong-xing BING, Shan-qing LI. Legend of Thoracic Surgery: the Earliest Exploration of Surgical Treatment for Esophageal Cancer in China was Carried Out in PUMCH[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 569-573. DOI: 10.3969/j.issn.1674-9081.2018.06.016
  • Cited by

    Periodical cited type(6)

    1. 王红英,张永刚,周丽君,张远,华军,张小伟. 基于儿科紧密型医联体构建区域新生儿聋病医防融合管理体系的理论与实践. 中国妇幼保健. 2024(03): 389-394 .
    2. 方丽,徐超. 遗传性耳聋相关基因突变检测试剂的注册现状及临床试验设计的关注点. 中国医疗器械信息. 2024(03): 1-3+46 .
    3. 阮宇,文铖,程晓华,张伟,谢锦各,李悦,邓琳,黄丽辉. 142例GJB2双等位基因突变患儿基因型与听力表型的差异分析. 中国耳鼻咽喉头颈外科. 2024(09): 569-573 .
    4. 黄银花,钟微微. 新生儿耳聋基因筛查结果分析. 罕少疾病杂志. 2024(11): 31-33 .
    5. 谢晓媛,冯树人,刘慧坤,王蕾棽,刘霞. 妊娠期遗传性耳聋易感基因携带者扩展型筛查模式研究. 国际妇产科学杂志. 2023(05): 514-518 .
    6. 张亚勤,杨涵,龙丹丹,陈怡颖,王金凤,乔宇,戴欢欢,苏洪. 云南普洱地区799例新生儿GJB2基因突变分析. 现代医药卫生. 2023(23): 3991-3996 .

    Other cited types(3)

Catalog

    Article Metrics

    Article views (1712) PDF downloads (191) Cited by(9)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close